‘Malaysia has secured deals to acquire 18.4 million doses of Covid-19 vaccines through Pharmaniaga Bhd and Duopharma Biotech Bhd. In separate announcements, Pharmaniaga said it would be supplying 12 million doses of Covid-19 vaccines developed by China’s Sinovac Life Sciences Co Ltd, while Duopharma said it would supply 6.4 million doses of Sputnik V developed by Russia’s Gamaleya Research Institute to the government.
‘Both companies yesterday said they had entered into a term sheet agreements to supply the Covid-19 vaccines to the Health Ministry. Pharmaniaga said it would begin manufacturing Sinovac Covid-19 vaccines in February and will deliver the bottled vaccines to identified hospitals and other healthcare facilities nationwide by April 2021.
Read here (The Star, Jan 27, 2021)
